Parallax Volatility Advisers’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-587,800
Closed -$17.4M 2504
2023
Q4
$17.4M Buy
587,800
+538,900
+1,102% +$10.7M 0.04% 429
2023
Q3
$776K Sell
48,900
-114,800
-70% -$1.91M ﹤0.01% 1462
2023
Q2
$3.09M Buy
+163,700
New +$1.93M 0.01% 963
2023
Q1
Sell
-32,500
Closed -$161K 3308
2022
Q4
$161K Sell
32,500
-17,500
-35% -$94.9K ﹤0.01% 2191
2022
Q3
$239K Hold
50,000
﹤0.01% 2263
2022
Q2
$225K Sell
50,000
-36,400
-42% -$158K ﹤0.01% 2169
2022
Q1
$411K Buy
+86,400
New +$478K ﹤0.01% 1970
2019
Q2
Sell
-22,500
Closed -$61K 3975
2019
Q1
$61K Buy
+22,500
New +$97.5K ﹤0.01% 2230

Other funds holding IMGN

Parallax Volatility Advisers's IMGN Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.18M sold.

Parallax Volatility Advisers first reported a position in IMGN in Q4 2017 and held it in 7 quarters. The position peaked at $384K in Q1 2023. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 100,000 Immunogen Inc shares in Q2 2023, an estimated $1.18M.
  • Parallax Volatility Advisers first reported a position in Immunogen Inc in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's Immunogen Inc position peaked at $384K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.